Search

everythinglearnresearchcommunity

for

Search:↓

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Some skin lymphomas can look like common skin issues and need careful testing to diagnose correctly.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

COVID-19 patients in Thailand typically started losing hair about 30 days after infection, with women experiencing more severe hair loss.

Caffeine penetrates skin quickly through open hair follicles, but less through closed ones, with levels becoming equal after 22 hours.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Hair loss in Saudi Arabia causes a low psychosocial impact, with less effect on those without a family history of hair loss.

Baicapil was effective in reducing hair loss and increasing hair growth in women with telogen effluvium.

DHT may increase the risk of heart disease and death in elderly men.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Hair loss in women in Lagos, Nigeria is not common, but when it happens, it's usually severe.

The study concluded that there is no significant link between thyroid autoimmunity and alopecia areata.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

The study found that the quality of cord blood units remains consistent before freezing and after thawing, indicating that attached tube segments reliably represent the graft's properties.

Monocytes might be linked to hair loss after COVID-19.

Kerion cases had longer disease duration but responded well to antifungal treatments.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

A drug called cimetidine can help treat hair loss in women by blocking androgen receptors. However, it's not the first choice and needs more research.

Artesunate is generally safe for severe malaria, but patients should be monitored for delayed anemia after treatment.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.